Cite
APA Citation
Eng, C., Baranda, J., Taylor, M., Gordon, M., Matulonis, U., Janku, F., Kornacker, M., Kamat, A., Rosen, O., Jimeno, A., & Eng, C. (n.d.). 418 A phase 1, dose escalation and dose expansion study of SQZ PBMC HPV as monotherapy and in combination with atezolizumab in HLA-A*02+ Patients with HPV16+ recurrent, or metastatic solid tumors. Journal for immunotherapy of cancer, 8, A444. http://access.bl.uk/ark:/81055/vdc_100144731137.0x000007